| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918146 | Radiotherapy and Oncology | 2015 | 8 Pages |
Abstract
Comorbidity significantly affects prognosis, especially in stages II and III, and should be incorporated into the TNM staging system for NPC. Assessment of comorbidity may improve outcome prediction and help tailor individualized treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Rui Guo, Xiao-Zhong Chen, Lei Chen, Feng Jiang, Ling-Long Tang, Yan-Ping Mao, Guan-Qun Zhou, Wen-Fei Li, Li-Zhi Liu, Li Tian, Ai-Hua Lin, Jun Ma,